pramocaine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
local anaesthetics 3487 140-65-8

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • pramocaine hydrochloride
  • pramoxine
  • pramoxine hydrochloride
  • pramocain
  • pramocaine
  • pramoxin
  • pramoxine HCl
  • Molecular weight: 293.41
  • Formula: C17H27NO3
  • CLOGP: 3.96
  • LIPINSKI: 0
  • HAC: 4
  • HDO: 0
  • TPSA: 30.93
  • ALOGS: -3.12
  • ROTB: 9
  • Status: OFP
    • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
kinase-safety-class ACVR2A,ACVR2B,AKT2,AKT3,ALK,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,ITK,JAK1,JAK2,MAP3K21,MAP3K7,MAPK10,MAPK12,MAPK7,MARK4,MET,MTOR,NTRK2,PAK4,PDK2,PDK4,PDPK1,PIK3CB,PIM2,PRKCD,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TTK,ULK1 48
kinase-selectivity-class GRK2,PDK4 2
pfas-class PFAS structural alert (1 = True, 0 = False) 0

Approvals:

DateAgencyCompanyOrphan
Aug. 13, 1976 FDA SEBELA IRELAND LTD

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Macular degeneration 1016.42 13.96 327 12878 37643 90577599
Chronic sinusitis 449.78 13.96 158 13047 23644 90591598
Female genital tract fistula 385.54 13.96 131 13074 17737 90597505
Paraesthesia oral 353.40 13.96 143 13062 31516 90583726
Procedural pain 342.78 13.96 142 13063 33218 90582024
Vaginal flatulence 338.09 13.96 109 13096 12529 90602713
Proctitis 321.83 13.96 110 13095 15149 90600093
Radiculopathy 316.02 13.96 114 13091 18391 90596851
Vaginal discharge 295.66 13.96 110 13095 19354 90595888
Oral candidiasis 244.34 13.96 114 13091 35341 90579901
Haematochezia 197.46 13.96 125 13080 70788 90544454
Frequent bowel movements 193.45 13.96 114 13091 56821 90558421
Colitis ulcerative 187.45 13.96 114 13091 60152 90555090
Rectal haemorrhage 184.59 13.96 127 13078 82617 90532625
Colitis 176.74 13.96 116 13089 69826 90545416
Therapeutic product effect incomplete 153.38 13.96 164 13041 193732 90421510
Dyspepsia 124.94 13.96 149 13056 198011 90417231
Erythema 106.21 13.96 148 13057 229098 90386144
Drug ineffective 79.92 13.96 404 12801 1383894 89231348
Constipation 78.67 13.96 144 13061 280251 90334991
Nasal polyps 71.86 13.96 34 13171 10846 90604396
Weight decreased 71.02 13.96 165 13040 379745 90235497
Anaemia 69.00 13.96 156 13049 352646 90262596
Abdominal pain 60.33 13.96 159 13046 395562 90219680
Infusion related reaction 58.07 13.96 162 13043 416618 90198624
Carbuncle 57.98 13.96 17 13188 1419 90613823
Urticaria thermal 53.65 13.96 13 13192 520 90614722
Monoclonal immunoglobulin present 51.42 13.96 17 13188 2107 90613135
Hypothalamo-pituitary disorder 50.45 13.96 17 13188 2235 90613007
Pyrexia 45.19 13.96 203 13002 660282 89954960
Amyloid arthropathy 42.90 13.96 14 13191 1666 90613576
Administration site erythema 42.22 13.96 12 13193 897 90614345
Salpingo-oophorectomy unilateral 41.47 13.96 12 13193 956 90614286
Asthma-chronic obstructive pulmonary disease overlap syndrome 40.82 13.96 18 13187 4881 90610361
Sinusitis fungal 40.76 13.96 14 13191 1950 90613292
Fibrosis 40.53 13.96 19 13186 5933 90609309
Total lung capacity increased 40.40 13.96 18 13187 5003 90610239
Nephropathy 38.06 13.96 21 13184 9214 90606028
Overweight 37.52 13.96 18 13187 5916 90609326
Embolism venous 35.75 13.96 15 13190 3605 90611637
Sputum increased 35.17 13.96 14 13191 2943 90612299
Wrist deformity 33.94 13.96 14 13191 3224 90612018
Malaise 31.35 13.96 168 13037 585818 90029424
Pulmonary pain 30.79 13.96 15 13190 5099 90610143
Hypomania 30.66 13.96 18 13187 8879 90606363
Cholelithiasis 30.59 13.96 38 13167 52468 90562774
Respiratory symptom 30.28 13.96 14 13191 4238 90611004
Jaundice cholestatic 28.65 13.96 18 13187 10025 90605217
Sarcoidosis 27.64 13.96 18 13187 10655 90604587
Pemphigus 27.27 13.96 7 13198 326857 90288385
Off label use 27.22 13.96 262 12943 1101990 89513252
Nail bed tenderness 26.97 13.96 7 13198 371 90614871
Proctalgia 26.72 13.96 16 13189 8182 90607060
Glossodynia 26.63 13.96 7 13198 321772 90293470
Joint swelling 26.18 13.96 21 13184 503279 90111963
Systemic lupus erythematosus 26.17 13.96 10 13195 361886 90253356
Dyslipidaemia 26.07 13.96 17 13188 10090 90605152
Therapeutic product effect delayed 25.96 13.96 12 13193 3629 90611613
Pigmentation disorder 25.82 13.96 14 13191 5935 90609307
Body height decreased 25.80 13.96 18 13187 11931 90603311
Diastolic dysfunction 25.70 13.96 15 13190 7318 90607924
Cardiac murmur 25.13 13.96 21 13184 18173 90597069
Contraindicated product administered 24.60 13.96 8 13197 320131 90295111
Rhinitis allergic 24.49 13.96 20 13185 16765 90598477
Vitamin B12 deficiency 22.83 13.96 14 13191 7472 90607770
Purpura 22.38 13.96 18 13187 14760 90600482
Hypersensitivity 22.38 13.96 20 13185 454657 90160585
Renal cyst 22.27 13.96 17 13188 12933 90602309
Schizophrenia 22.24 13.96 18 13187 14896 90600346
Hand deformity 21.74 13.96 8 13197 296354 90318888
Scratch 21.62 13.96 15 13190 9851 90605391
Skin plaque 21.47 13.96 15 13190 9960 90605282
Secretion discharge 21.23 13.96 18 13187 15878 90599364
Dizziness postural 20.40 13.96 14 13191 9039 90606203
Pericarditis 20.31 13.96 7 13198 270144 90345098
Bone density decreased 19.88 13.96 18 13187 17327 90597915
Bronchiectasis 19.58 13.96 20 13185 22310 90592932
Wound 19.34 13.96 10 13195 302970 90312272
Death 19.17 13.96 23 13182 456528 90158714
Fungal infection 18.89 13.96 27 13178 42634 90572608
Emphysema 18.83 13.96 15 13190 12140 90603102
Nausea 18.31 13.96 244 12961 1110072 89505170
Osteoporosis 18.04 13.96 42 13163 96489 90518753
Autonomic neuropathy 17.83 13.96 7 13198 1420 90613822
Rheumatoid arthritis 17.77 13.96 16 13189 362598 90252644
Jarisch-Herxheimer reaction 16.89 13.96 5 13200 431 90614811
Diverticulum 16.76 13.96 14 13191 12099 90603143
Anti-cyclic citrullinated peptide antibody positive 16.32 13.96 7 13198 236426 90378816
Pain 16.01 13.96 218 12987 996123 89619119
Aplastic anaemia 15.66 13.96 14 13191 13255 90601987
Dermatophytosis 15.39 13.96 4 13201 213 90615029
Movement disorder 15.32 13.96 20 13185 28999 90586243
Maternal exposure during pregnancy 15.25 13.96 18 13187 360045 90255197
Hysterectomy 15.23 13.96 13 13192 11571 90603671
Discomfort 14.81 13.96 11 13194 274324 90340918
Dysstasia 14.38 13.96 18 13187 25034 90590208
Fatigue 14.34 13.96 104 13101 1153919 89461323
Treatment failure 14.20 13.96 14 13191 303914 90311328
Peripheral swelling 14.17 13.96 24 13181 413082 90202160
Limb injury 14.03 13.96 20 13185 31488 90583754

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Anal inflammation 143.43 18.19 34 3523 2195 42615583
SARS-CoV-2 test negative 134.94 18.19 31 3526 1744 42616034
Accident 107.38 18.19 34 3523 6469 42611309
Proctalgia 104.47 18.19 34 3523 7059 42610719
Haemorrhoids 88.34 18.19 38 3519 17059 42600719
Body temperature increased 72.74 18.19 35 3522 20323 42597455
Febrile neutropenia 35.64 18.19 59 3498 185644 42432134
Chills 31.51 18.19 39 3518 94027 42523751
Back pain 31.24 18.19 48 3509 141728 42476050
Pruritus 31.01 18.19 56 3501 188715 42429063
Pyrexia 29.96 18.19 86 3471 393956 42223822
Anticholinergic syndrome 24.94 18.19 8 3549 1581 42616197
Erythema multiforme 23.58 18.19 13 3544 9964 42607814
Diarrhoea 21.18 18.19 85 3472 460764 42157014
Pain 21.07 18.19 56 3501 244792 42372986
Neutropenia 18.57 18.19 47 3510 199384 42418394

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Chronic sinusitis 445.81 15.53 155 14390 24929 110549825
Macular degeneration 440.23 15.53 148 14397 21511 110553243
Female genital tract fistula 404.64 15.53 130 14415 16389 110558365
Paraesthesia oral 352.03 15.53 141 14404 33530 110541224
Vaginal flatulence 349.09 15.53 108 14437 12036 110562718
Procedural pain 341.15 15.53 140 14405 35425 110539329
Radiculopathy 318.69 15.53 113 14432 19223 110555531
Proctitis 317.74 15.53 109 14436 16818 110557936
Vaginal discharge 311.73 15.53 109 14436 17799 110556955
Oral candidiasis 227.16 15.53 113 14432 44647 110530107
Frequent bowel movements 182.89 15.53 115 14430 71275 110503479
Colitis ulcerative 172.00 15.53 114 14431 77249 110497505
Rectal haemorrhage 162.63 15.53 131 14414 119702 110455052
Haematochezia 162.56 15.53 129 14416 115395 110459359
Colitis 158.60 15.53 121 14424 102202 110472552
Therapeutic product effect incomplete 142.61 15.53 161 14384 223644 110351110
Dyspepsia 141.93 15.53 149 14396 190816 110383938
Anal inflammation 119.51 15.53 33 14512 2463 110572291
Proctalgia 116.40 15.53 49 14496 13173 110561581
SARS-CoV-2 test negative 110.20 15.53 30 14515 2123 110572631
Erythema 94.79 15.53 151 14394 291296 110283458
Pyrexia 72.11 15.53 270 14275 897995 109676759
Weight decreased 71.96 15.53 177 14368 467880 110106874
Nasal polyps 71.90 15.53 35 14510 13165 110561589
Accident 71.82 15.53 33 14512 10919 110563835
Constipation 69.00 15.53 148 14397 357638 110217116
Infusion related reaction 60.52 15.53 146 14399 381016 110193738
Carbuncle 59.34 15.53 17 14528 1450 110573304
Malaise 57.21 15.53 206 14339 671613 109903141
Urticaria thermal 55.02 15.53 13 14532 518 110574236
Administration site erythema 52.10 15.53 12 14533 427 110574327
Abdominal pain 51.26 15.53 166 14379 512823 110061931
Pain 50.34 15.53 253 14292 954702 109620052
Monoclonal immunoglobulin present 50.15 15.53 17 14528 2523 110572231
Haemorrhoids 48.33 15.53 39 14506 35633 110539121
Hypothalamo-pituitary disorder 48.25 15.53 17 14528 2829 110571925
Anaemia 46.73 15.53 168 14377 546918 110027836
Total lung capacity increased 45.17 15.53 19 14526 5093 110569661
Salpingo-oophorectomy unilateral 44.50 15.53 12 14533 819 110573935
Amyloid arthropathy 44.31 15.53 14 14531 1666 110573088
Asthma-chronic obstructive pulmonary disease overlap syndrome 41.23 15.53 19 14526 6325 110568429
Overweight 37.81 15.53 18 14527 6446 110568308
Sinusitis fungal 37.70 15.53 14 14531 2706 110572048
Embolism venous 35.66 15.53 16 14529 5007 110569747
Wrist deformity 35.54 15.53 14 14531 3175 110571579
Hypomania 32.70 15.53 19 14526 10191 110564563
Fibrosis 32.09 15.53 17 14528 7625 110567129
Body temperature increased 30.81 15.53 37 14508 54676 110520078
Rhinitis allergic 29.51 15.53 22 14523 17900 110556854
Body height decreased 29.51 15.53 18 14527 10545 110564209
Pulmonary pain 29.29 15.53 15 14530 6278 110568476
Sarcoidosis 29.04 15.53 19 14526 12560 110562194
Nephropathy 27.86 15.53 19 14526 13448 110561306
Sputum increased 27.62 15.53 14 14531 5737 110569017
Nail bed tenderness 27.57 15.53 7 14538 377 110574377
Cholelithiasis 26.49 15.53 37 14508 63385 110511369
Jaundice cholestatic 26.47 15.53 19 14526 14589 110560165
Chills 26.00 15.53 69 14476 190511 110384243
Pigmentation disorder 24.46 15.53 14 14531 7297 110567457
Scratch 23.79 15.53 17 14528 12962 110561792
Bone density decreased 22.71 15.53 18 14527 16024 110558730
Death 22.28 15.53 36 14509 698833 109875921
Therapeutic product effect delayed 21.79 15.53 11 14534 4468 110570286
Joint swelling 21.63 15.53 16 14529 442829 110131925
Dyslipidaemia 20.66 15.53 17 14528 15948 110558806
Hysterectomy 20.57 15.53 13 14532 8101 110566653
Vitamin B12 deficiency 20.36 15.53 14 14531 10041 110564713
Toxicity to various agents 20.26 15.53 20 14525 480535 110094219
Schizophrenia 19.79 15.53 19 14526 21807 110552947
Drug interaction 19.75 15.53 22 14523 500161 110074593
Skin plaque 19.66 15.53 15 14530 12630 110562124
Cardiac murmur 19.66 15.53 20 14525 24608 110550146
Completed suicide 19.60 15.53 4 14541 242377 110332377
Renal cyst 18.75 15.53 17 14528 18155 110556599
Off label use 18.52 15.53 288 14257 1499897 109074857
Diastolic dysfunction 17.73 15.53 14 14531 12390 110562364
Nausea 17.49 15.53 243 14302 1235447 109339307
Product administration error 17.49 15.53 23 14522 37194 110537560
Secretion discharge 17.19 15.53 17 14528 20227 110554527
Headache 16.55 15.53 183 14362 882194 109692560
Bronchiectasis 16.31 15.53 22 14523 36471 110538283
Purpura 16.26 15.53 18 14527 24370 110550384
Fatigue 16.12 15.53 94 14451 1215864 109358890
Febrile neutropenia 15.93 15.53 83 14462 316684 110258070
Limb injury 15.78 15.53 22 14523 37614 110537140
Dizziness postural 15.73 15.53 14 14531 14595 110560159
Vulvovaginal swelling 15.72 15.53 5 14540 608 110574146

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC C05AD07 CARDIOVASCULAR SYSTEM
VASOPROTECTIVES
AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
Local anesthetics
ATC D04AB07 DERMATOLOGICALS
ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
Anesthetics for topical use
MeSH PA D000777 Anesthetics
MeSH PA D000779 Anesthetics, Local
MeSH PA D002491 Central Nervous System Agents
MeSH PA D002492 Central Nervous System Depressants
MeSH PA D018373 Peripheral Nervous System Agents
MeSH PA D018689 Sensory System Agents
CHEBI has role CHEBI:36333 local anaesthetic
CHEBI has role CHEBI:67079 anti-inflammatory agent

Related Drugs by ATC class:

C05AD Local anesthetics 6 drugs
benzocainecinchocainelidocaineoxetacaineprocainetetracaine
D04AB Anesthetics for topical use 6 drugs
benzocainecinchocainelidocaineoxybuprocainequinisocainetetracaine

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Otitis externa indication 3135009
Proctitis indication 3951002 DOID:3127
Tinea pedis indication 6020002 DOID:12403
Wound indication 13924000
Dry skin indication 16386004
Burn injury indication 48333001
Hemorrhoids indication 70153002 DOID:9746
Rectal pain indication 77880009
Tinea corporis indication 84849002
Pruritus ani indication 90446007
Eruption of skin indication 271807003 DOID:0050486
Skin irritation indication 367466007
Tinea cruris indication 399029005
Allergic otitis externa indication 405821001
Arthropod bite wound indication 409985002
Itching of skin indication 418363000
Itching of ear indication 699392007
Inflammatory dermatosis indication 703938007
Prevent Minor Bacterial Skin Infection indication
Minor Skin Wound Pain indication
Minor Bacterial Skin Infections indication
Mycosis contraindication 3218000 DOID:1564
Measles contraindication 14189004 DOID:8622
Herpes zoster auricularis contraindication 21954000 DOID:9210
Abscess of intestine contraindication 24557004
Acute tuberculosis contraindication 25629007
Hyperthyroidism contraindication 34486009 DOID:7998
Gastrointestinal fistula contraindication 37831005
Hypertensive disorder contraindication 38341003 DOID:10763
Contact dermatitis contraindication 40275004 DOID:2773
Infectious disease contraindication 40733004
Hypothyroidism contraindication 40930008 DOID:1459
Conduction disorder of the heart contraindication 44808001
Skin ulcer contraindication 46742003
Chronic heart failure contraindication 48447003
Anxiety contraindication 48694002
Perforation of tympanic membrane contraindication 60442001
Osteoporosis contraindication 64859006 DOID:11476
Psychotic disorder contraindication 69322001
Diabetes mellitus contraindication 73211009 DOID:9351
Third degree burn injury contraindication 80247002
Open-angle glaucoma contraindication 84494001 DOID:1067
Herpes simplex contraindication 88594005 DOID:8566
Kidney disease contraindication 90708001 DOID:557
Fissure in skin contraindication 95321009
Open wound contraindication 125643001
Tuberculosis of ear contraindication 186269001
Ophthalmic herpes simplex contraindication 186542001
Anastomosis of intestine contraindication 235407009
Telangiectasia disorder contraindication 247479008
Benign prostatic hyperplasia contraindication 266569009
Diverticulitis of gastrointestinal tract contraindication 271366000
Varicella-zoster virus infection contraindication 309465005
Viral ear infection contraindication 312137007
Fungal ear infection contraindication 312148000
Adrenal cortical hypofunction contraindication 386584007 DOID:10493
Atrophoderma contraindication 399979006
Peripheral vascular disease contraindication 400047006
Disorder of coronary artery contraindication 414024009
Denuded skin contraindication 418242004
Nervousness contraindication




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 7.65 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])		Mechanism
action		Bioact sourceMoA source
Sigma non-opioid intracellular receptor 1 Membrane receptor Ki 7.29 DRUG MATRIX
Sodium channel alpha subunits; brain (Types I, II, III) Ion channel IC50 4.67 CHEMBL
Membrane-associated progesterone receptor component 1 Membrane receptor Ki 6.20 DRUG MATRIX

External reference:

IDSource
4018983 VUID
N0000171570 NUI
D00739 KEGG_DRUG
637-58-1 SECONDARY_CAS_RN
4018197 VANDF
4018983 VANDF
C0071810 UMLSCUI
CHEBI:8357 CHEBI
PX9 PDB_CHEM_ID
CHEMBL1198 ChEMBL_ID
CHEMBL1201171 ChEMBL_ID
DB09345 DRUGBANK_ID
C005548 MESH_SUPPLEMENTAL_RECORD_UI
4886 PUBCHEM_CID
34347 RXNORM
5341 MMSL
5342 MMSL
72272 MMSL
001359 NDDF
004571 NDDF
31872002 SNOMEDCT_US
387175007 SNOMEDCT_US
387284004 SNOMEDCT_US
235 INN_ID
068X84E056 UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
PROCTOFOAMHC HUMAN PRESCRIPTION DRUG LABEL 2 0037-6822 AEROSOL, FOAM 100 mg TOPICAL ANDA 22 sections
PROCTOFOAMNS HUMAN OTC DRUG LABEL 1 0037-6823 AEROSOL, FOAM 150 mg RECTAL OTC Monograph Drug 11 sections
EPIFOAM HUMAN PRESCRIPTION DRUG LABEL 2 0037-6824 AEROSOL, FOAM 100 mg TOPICAL ANDA 20 sections
Good Sense Triple Antibioticand Pain Relief HUMAN OTC DRUG LABEL 4 0113-0679 OINTMENT 10 mg TOPICAL OTC Monograph Drug 13 sections
Good Sense HemorrhoidalMaximum Strength Pain Relief HUMAN OTC DRUG LABEL 4 0113-0944 CREAM 1 g TOPICAL OTC Monograph Drug 14 sections
good sense triple antibiotic HUMAN OTC DRUG LABEL 4 0113-1140 OINTMENT 10 mg TOPICAL OTC Monograph Drug 13 sections
Caladryl HUMAN OTC DRUG LABEL 3 0187-5465 LOTION 10 mg TOPICAL OTC Monograph Drug 14 sections
Caladryl Clear HUMAN OTC DRUG LABEL 2 0187-5466 LOTION 10 mg TOPICAL OTC Monograph Drug 14 sections
ITCH X HUMAN OTC DRUG LABEL 2 0225-0495 GEL 1 g TOPICAL OTC Monograph Drug 14 sections
ITCH-X HUMAN OTC DRUG LABEL 2 0225-0516 SPRAY 1 g TOPICAL OTC monograph not final 13 sections
Sarna HUMAN OTC DRUG LABEL 1 0316-0230 LOTION 10 mg TOPICAL OTC Monograph Drug 14 sections
Sarna HUMAN OTC DRUG LABEL 1 0316-0230 LOTION 10 mg TOPICAL OTC Monograph Drug 14 sections
Sarna HUMAN OTC DRUG LABEL 1 0316-0230 LOTION 10 mg TOPICAL OTC Monograph Drug 14 sections
Sarna HUMAN OTC DRUG LABEL 2 0316-0234 LOTION 10 mg TOPICAL OTC Monograph Drug 13 sections
Sarna HUMAN OTC DRUG LABEL 2 0316-0234 LOTION 10 mg TOPICAL OTC Monograph Drug 13 sections
Triple Antibiotic with Pain ReliefMaximum Strength HUMAN OTC DRUG LABEL 4 0363-0123 OINTMENT 10 mg TOPICAL OTC MONOGRAPH FINAL 13 sections
Walgreen Anti-Itch HUMAN OTC DRUG LABEL 1 0363-0263 LOTION 1 g TOPICAL OTC Monograph Drug 13 sections
Hemorrhoidal Cream HUMAN OTC DRUG LABEL 4 0363-0641 CREAM 10 mg TOPICAL OTC Monograph Drug 15 sections
Hemorrhoidal Cream HUMAN OTC DRUG LABEL 4 0363-0641 CREAM 10 mg TOPICAL OTC Monograph Drug 15 sections
First Aid Antibiotic HUMAN OTC DRUG LABEL 4 0363-0841 OINTMENT 10 mg TOPICAL OTC Monograph Drug 13 sections
Walgreens Maximum Strength Hemorrhoidal HUMAN OTC DRUG LABEL 4 0363-1760 CREAM 0.01 mg TOPICAL OTC monograph final 13 sections
Walgreens Kids Multi-Antibiotic with Pain Relief Cream HUMAN OTC DRUG LABEL 3 0363-2122 CREAM 10 mg TOPICAL OTC Monograph Drug 11 sections
Walgreens Multi-Antibiotic with Pain Relief Cream HUMAN OTC DRUG LABEL 3 0363-2123 CREAM 10 mg TOPICAL OTC Monograph Drug 9 sections
MEDICATED ANTI-ITCHWell at Walgreens HUMAN OTC DRUG LABEL 2 0363-3231 CREAM 1 g TOPICAL OTC monograph not final 12 sections
triple antibiotic pain relief HUMAN OTC DRUG LABEL 4 0363-6790 OINTMENT 10 mg TOPICAL OTC Monograph Drug 13 sections
Walgreens Maximum Strength Triple Antibiotic With Pain Relief HUMAN OTC DRUG LABEL 4 0363-7872 OINTMENT 10 mg TOPICAL OTC monograph final 11 sections
Calamine Plus Pramoxine HCl HUMAN OTC DRUG LABEL 3 0363-8588 AEROSOL, SPRAY 2.72 mg TOPICAL OTC Monograph Drug 12 sections
Calamine Plus Pramoxine HCl HUMAN OTC DRUG LABEL 3 0363-8588 AEROSOL, SPRAY 2.72 mg TOPICAL OTC Monograph Drug 12 sections
Triple Antibiotic Plus Pain Relief HUMAN OTC DRUG LABEL 4 0363-8888 OINTMENT 10 mg TOPICAL OTC Monograph Drug 14 sections
Hemorrhoidal Pain Relief Cream HUMAN OTC DRUG LABEL 4 0363-9127 CREAM 10 mg TOPICAL OTC Monograph Drug 15 sections